Prognostic methods for breast cancer

Details Prognostic methods for breast cancer Prognostic methods for breast cancer

2006-06-06

2006-06-06

Horlick, Kenneth R. (Department: 1637)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

07056663

ABSTRACT:
Methods of determining the likelihood of the re-occurrence of tumors and of determining the aggressiveness of post-surgical treatment are provided which rely on analysis of a loss of heterogeneity at the particular chromosomal locus 3p24.3. Loss of expression or hypermethylation of the thyroid hormone receptor β1 gene is also predictive of an increased re-occurrence of tumors.

REFERENCES:
patent: 2001/0039015 (2001-11-01), Sauter
patent: 2002/0055096 (2002-05-01), Deng et al.
patent: WO 98/17828 (1998-04-01), None
Deng et al. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas. Science, vol. 274, pp. 2057-2059, Dec. 1996.
Blumenstein et al. International Journal of Oncology, vol. 21, pp. 447-450, 2002.
Ali, Iqbal Unnisa, et al., “Presence of Two Members of c-erbA Receptor Gene Family (C-erbAβ and c-erbA2) in Smallest Region of Somatic Homozygosity on Chromosome 3p21-p25 in Human Breast Carcinoma,”Journal of the National Cancer Institute, Dec. 6, 1989, pp. 1815-1820, vol. 81, No. 23.
Chen, Ling-Chun, et al., “Heterogeneity for Allelic Loss in Human Breast Cancer,”Journal of the National Cancer Institute, Apr. 1, 1992, pp. 506-510, vol. 84, No. 7.
Chen, Ling-Chun, et al., “Deletion of Two Separate Regions on Chromosome 3p in Breast Cancers,”Cancer Research, Jun. 1, 1994, pp. 3021-3024, vol. 54, No. 11.
Deng, Guoren, et al., “Loss of Heterozygosity andp53Gene Mutations in Breast Cancer,”Cancer Research, Jan. 15, 1994, pp. 499-505, vol. 54, No. 2.
Deng, Guoren, et al., “Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas,”Science, Dec. 20, 1996, vol. 274.
Matsumoto, Satoshi, et al., “Detailed Deletion Mapping of Chromosome Arm 3p in Breast Cancers: A 2-cM Region on 3p14.3-21.1 and a 5-cM Region on 3p24.3-25.1 Commonly Deleted in Tumors,”Genes, Chromosomes and Cancer, 1997, pp. 268-274, vol. 20.
Matsumoto, Satoshi, et al., “Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer,”Cancer Letters, Apr. 28, 2000, pp. 63-69, vol. 152, No. 1.
O'Connell, Peter, et al., “Molecular genetic studies of early breast cancer evolution,”Breast Cancer Research and Treatment, 1994, pp. 5-12, vol. 32.

Affiliated with

Also associated with

Rating

Prognostic methods for breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prognostic methods for breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prognostic methods for breast cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3678918